Filter This View

  • March 9, 2010 |

    White & Case makes up five new partners in wake of recent losses

    White & Case has made an additional partner promotions round in a bid to rebuild its partnership following a number of high-profile departures in recent weeks. The US firm has made up five new partners with immediate effect.

    1 minute read

  • March 3, 2010 |

    White & Case rebuilds in London with Skadden restructuring hire

    White & Case has made its first hire in London since the loss of six City partners earlier this year. Skadden Arps Slate Meagher & Flom restructuring lawyer Chris Pilkington will join White & Case as a partner in April, having been at Skadden since October 2004. He was promoted to the rank of senior counsel in May 2008.

    1 minute read

  • March 2, 2010 |

    Skadden heads up trio of firms on $7.2bn Merck acquisition

    A trio of firms have advised on a $7.2bn (£4.8bn) deal that will see German pharma giant Merck acquire lab filter and purifier manufacturer Millipore, reports The Am Law Daily. Skadden took the lead role for Merck, fielding a team including M&A partners Peter Atkins, Hilary Foulkes and Margaret Brown, tax partner Sally Thurston, antitrust partners Frederic Depoortere, Benjamin Crisman and John Lyons, and intellectual property and technology partner Rita Rodin Johnston.

    1 minute read

  • February 26, 2010 |

    Skadden and Cleary take top roles on $12bn Coca-Cola buyout

    Skadden Arps Slate Meagher & Flom has advised Coca-Cola on its $12.2bn (£8bn) deal to acquire the North American operations of its largest bottler, Coca-Cola Enterprises, reports The Am Law Daily. The deal follows PepsiCo's move in August to take control of its two largest bottlers for $7.8bn (£5.1bn).

    1 minute read

  • February 19, 2010 |

    SJ Berwin and Freshfields head up $755m private equity group sale

    SJ Berwin and Freshfields Bruckhaus Deringer have acted on the $755m (£490m) sale of UK private equity group Pantheon, a deal which has also handed roles to a trio of US firms. Freshfields advised acquisitive US money-holding company Affiliated Managers Group (AMG) on its proposed purchase of Pantheon - a private equity fund-of-funds manager - from Russell Investments.

    1 minute read

  • February 15, 2010 |

    Bingham sets standard for London salaries with £100,000 pay for NQs

    Bingham McCutchen has emerged as one of the best-paying firms for newly-qualified (NQ) lawyers in London with NQ salaries of more than £100,000. The firm said that it pays New York rates, which currently stand at around $160,000 (£102,000) for NQs.

    1 minute read

  • February 11, 2010 |

    Linklaters partner joins Darrois Villey in trio of hires for French leader

    Leading French law firm Darrois Villey Maillot Brochier has bolstered its practice with the hire of three new partners, including one from Linklaters. Corporate partner Bertrand Cardi joins Darrois, having been a partner at Linklaters in Paris since 2004. He joined the magic circle firm as an associate in 2000, having previously worked with Gide Loyrette Nouel.

    1 minute read

  • January 29, 2010 |

    Ropes & Gray builds City office with hire of Weil restructuring partner

    Ropes & Gray is set to bring in Weil Gotshal & Manges restructuring partner Tony Horspool. Horspool is expected to join the Boston firm on 1 March, less than two years after joining Weil from Cadwalader Wickersham & Taft in April 2008.

    1 minute read

  • January 26, 2010 |

    Skadden and Latham land roles on $4bn Japanese telecoms deal

    A trio of US firms have taken lead roles on Liberty Global's $4bn (£2.5bn) sell-off of its minority stake in Japan's largest cable company to mobile phone operator KDDI, reports The Am Law Daily. Skadden Arps Slate Meagher & Flom advised Japan's KDDI on the acquisition of Liberty's 38% stake in Jupiter Telecommunications, fielding a team led by Tokyo-based partner Mitsuhiro Kamiya.

    1 minute read

  • January 21, 2010 |

    No more baby steps

    Nothing was ordinary about the first civil trial stemming from Pfizer's controversial epilepsy treatment, Neurontin. Both sides loudly complained about witness intimidation. Colourful plaintiffs lawyer Mark Lanier opened to the jury one day, then settled the next after an anonymous donor deposited $50,000 (£31,000) into an account for the alleged victim's daughter. And at the defence table, high-powered product liability specialists from three separate firms worked as though they were partners - and all on a flat fee basis. "It was," says Pfizer general counsel Amy Schulman, "an extraordinary victory."

    1 minute read